Clinical Trial Update: RCT Study on Granulocyte Colony-stimulating Factor(G-CSF) Treatment of Hepatic Failure [Phase 4]

View source ↗

Summary

This clinical trial update reports a Phase 4 randomized study of granulocyte colony-stimulating factor (filgrastim) for hepatic failure, with current status lis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Liver Disease
• Hepatitis B
• Liver Failure

Drugs mentioned

• Filgrastim (filgrastim)

Snippet

Sponsor: Beijing 302 Hospital | Conditions: Liver Failure, Hepatitis B | Phase 4 | Status: UNKNOWN